• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培训初级保健专业人员进行多种疾病管理:eMULTIPAP 课程的教育评估。

Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course.

机构信息

Teaching Unit for Family and Community Primary Care Health District Málaga/Guadalhorce, Andalusian Health Service, Málaga, Spain; Biomedical Research Institute of Málaga -IBIMA-, University of Malaga, Spain; Health Services and Chronic Conditions Research Network (REDISSEC), Health Institute Carlos III, Madrid, Spain.

Health Services and Chronic Conditions Research Network (REDISSEC), Health Institute Carlos III, Madrid, Spain; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.

出版信息

Mech Ageing Dev. 2020 Dec;192:111354. doi: 10.1016/j.mad.2020.111354. Epub 2020 Sep 15.

DOI:10.1016/j.mad.2020.111354
PMID:32946885
Abstract

Multimorbidity (MM) is a widespread problem and it poses unsolved issues like the healthcare professionals' training. A training curriculum has been proposed, but it has not been sufficiently explored in a clinical context. The eMULTIPAP course is part of the MULTIPAP complex intervention, applied through a pragmatic controlled, cluster randomized clinical trial to general practitioners (GP) and his/her patients with MM with 12 months follow-up. The eMULTIPAP course is based on problem-based learning, constructivism and Ariadne principles. It has been assessed according to the Kirkpatrick model and has shown knowledge improvement and high applicability of learning with more motivation to consider MM in the clinical practice. It has also improved the Medication Appropriateness Index at 6-months and at 12- months. We conclude that the eMULTIPAP course generates significant changes in GP's learning, enhancing clinical practice in multimorbidity scenarios.

摘要

多发病(MM)是一个普遍存在的问题,它提出了一些未解决的问题,如医疗保健专业人员的培训。已经提出了一个培训课程,但在临床环境中尚未得到充分探索。eMULTIPAP 课程是 MULTIPAP 综合干预的一部分,通过实用的对照、群组随机临床试验应用于全科医生(GP)及其患有 MM 的患者,随访 12 个月。eMULTIPAP 课程基于基于问题的学习、建构主义和阿里阿德涅原则。它已经根据柯克帕特里克模型进行了评估,并且已经显示出了知识的提高和学习的高适用性,并且更有动力在临床实践中考虑 MM。它还改善了 6 个月和 12 个月时的药物适宜性指数。我们得出结论,eMULTIPAP 课程在 GP 的学习中产生了显著的变化,增强了多发病情况下的临床实践。

相似文献

1
Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course.培训初级保健专业人员进行多种疾病管理:eMULTIPAP 课程的教育评估。
Mech Ageing Dev. 2020 Dec;192:111354. doi: 10.1016/j.mad.2020.111354. Epub 2020 Sep 15.
2
MULTIPAP Study: Improving healthcare for patients with multimorbidity.多重疾病研究:改善患有多种疾病患者的医疗保健服务。
Br J Gen Pract. 2020 Jun;70(suppl 1). doi: 10.3399/bjgp20X711257.
3
Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).一项改善患有多种疾病和使用多种药物的初级保健患者药物处方的干预措施的有效性:一项整群随机临床试验的研究方案(多药多症项目)
Implement Sci. 2017 Apr 27;12(1):54. doi: 10.1186/s13012-017-0584-x.
4
How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention.如何改善基层医疗中患有多种疾病和使用多种药物的患者的医疗服务:MULTIPAP干预的实用整群随机临床试验
J Pers Med. 2022 May 6;12(5):752. doi: 10.3390/jpm12050752.
5
Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.多模式干预在患有多种疾病和多种药物治疗的最年轻老年人中的有效性,旨在改善初级保健中的处方实践:一项集群随机试验的研究方案。
Trials. 2022 Jun 9;23(1):479. doi: 10.1186/s13063-022-06293-x.
6
Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.根据患有多种合并症和多种药物治疗的患者的明确和隐含标准,潜在不适当的处方。MULTIPAP:一项横断面研究。
PLoS One. 2020 Aug 12;15(8):e0237186. doi: 10.1371/journal.pone.0237186. eCollection 2020.
7
Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trial.以患者为中心的药物评估对基层医疗患者多重用药的影响:一项整群随机对照试验的研究方案
Trials. 2015 Aug 26;16:380. doi: 10.1186/s13063-015-0915-7.
8
Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.在初级保健中支持多病共存和大量用药的老年人处方(SPPiRE):一项集群随机对照试验方案和试点研究。
Implement Sci. 2017 Aug 1;12(1):99. doi: 10.1186/s13012-017-0629-1.
9
Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.一项综合干预措施对基层医疗中多重疾病患者多重用药优先排序(PRIMUM)的效果:一项实用整群随机对照试验的结果
BMJ Open. 2018 Feb 24;8(2):e017740. doi: 10.1136/bmjopen-2017-017740.
10
Impact of a tailored program on the implementation of evidence-based recommendations for multimorbid patients with polypharmacy in primary care practices-results of a cluster-randomized controlled trial.一项量身定制的项目对基层医疗实践中患有多种疾病且使用多种药物的患者实施循证推荐的影响——一项整群随机对照试验的结果
Implement Sci. 2017 Jan 13;12(1):8. doi: 10.1186/s13012-016-0535-y.

引用本文的文献

1
Capacity building models for managing multiple long-term conditions in low-and-middle-income countries: a systematic review and gap analysis.中低收入国家管理多种长期病症的能力建设模式:系统评价与差距分析
Hum Resour Health. 2025 Jul 30;23(1):38. doi: 10.1186/s12960-025-00996-3.
2
Multimorbidity Management: A Scoping Review of Interventions and Health Outcomes.多重疾病管理:干预措施与健康结果的范围综述
Int J Environ Res Public Health. 2025 May 13;22(5):770. doi: 10.3390/ijerph22050770.
3
Barriers and Unmet Educational Needs Regarding Implementation of Medication Adherence Management Across Europe: Insights from COST Action ENABLE.
跨欧药物依从性管理实施的障碍和未满足的教育需求:COST 行动 ENABLE 的洞察。
J Gen Intern Med. 2024 Nov;39(15):2917-2926. doi: 10.1007/s11606-024-08851-2. Epub 2024 Jun 28.
4
Multimorbidity and acute infectious diseases in urban and semi-urban settings in Peru: A mixed-methods study.秘鲁城市和半城市地区的多重疾病与急性传染病:一项混合方法研究。
J Multimorb Comorb. 2024 May 23;14:26335565241256826. doi: 10.1177/26335565241256826. eCollection 2024 Jan-Dec.
5
Association between physical multimorbidity and common mental health disorders in rural and urban Malawian settings: Preliminary findings from Healthy Lives Malawi long-term conditions survey.马拉维农村和城市地区身体多种疾病与常见精神健康障碍之间的关联:马拉维健康生活长期疾病调查的初步结果。
PLOS Glob Public Health. 2024 Apr 4;4(4):e0002955. doi: 10.1371/journal.pgph.0002955. eCollection 2024.
6
Digital Medication Management in Polypharmacy.数字化药物管理在复方用药中的应用。
Dtsch Arztebl Int. 2024 Apr 19;121(8):243-250. doi: 10.3238/arztebl.m2024.0007.
7
Use of an Electronic Medication Management Support System in Patients with Polypharmacy in General Practice: A Quantitative Process Evaluation of the AdAM Trial.电子药物管理支持系统在综合医疗中多重用药患者中的应用:AdAM试验的定量过程评估
Pharmaceuticals (Basel). 2022 Jun 17;15(6):759. doi: 10.3390/ph15060759.
8
Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.多模式干预在患有多种疾病和多种药物治疗的最年轻老年人中的有效性,旨在改善初级保健中的处方实践:一项集群随机试验的研究方案。
Trials. 2022 Jun 9;23(1):479. doi: 10.1186/s13063-022-06293-x.
9
How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention.如何改善基层医疗中患有多种疾病和使用多种药物的患者的医疗服务:MULTIPAP干预的实用整群随机临床试验
J Pers Med. 2022 May 6;12(5):752. doi: 10.3390/jpm12050752.
10
Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey.确定基层医疗专业人员的多重疾病培训需求:一项调查方案
J Multimorb Comorb. 2021 Jun 21;11:26335565211024791. doi: 10.1177/26335565211024791. eCollection 2021 Jan-Dec.